<DOC>
	<DOCNO>NCT00052676</DOCNO>
	<brief_summary>RATIONALE : It yet know whether inject technetium Tc 99m sulfur colloid blue dye near tumor effective injecting near nipple identify sentinel lymph node patient stage I stage II breast cancer . PURPOSE : Randomized diagnostic trial compare effectiveness inject technetium Tc 99m sulfur colloid blue dye near tumor injection around nipple detect sentinel lymph node patient stage I stage II breast cancer .</brief_summary>
	<brief_title>Technetium Tc 99m Sulfur Colloid Blue Dye In Detecting Sentinel Lymph Nodes Patients With Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine optimal mode injection ( peritumoral v periareolar ) patent blue V dye technetium Tc 99m sulfur colloid patient stage I II breast cancer undergo sentinel lymph node identification . - Determine reduction morbidity associate breast cancer surgery , term local control survival , patient undergoing sentinel lymph node identification drug . - Determine evolution disease patient undergone procedure show histological invasion sentinel lymph node . OUTLINE : This randomize , multicenter study . Patients stratify accord participate center . Patients randomize 1 2 treatment arm . - Arm I : Patients receive peritumoral injection patent blue V dye technetium Tc 99m sulfur colloid . - Arm II : Patients receive periareolar injection arm I . Patients arm show histological metastasis sentinel lymph node without identification sentinel lymph node undergo standard axillary lymph node dissection . Patients follow disease evolution . PROJECTED ACCRUAL : A total 450 patient ( 225 per arm ) accrue study within 2-2.5 year .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Technetium Tc 99m Sulfur Colloid</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm invasive breast cancer T0 , T1 , T2 great 3 cm , N0 Amenable surgery No inflammatory breast cancer No ductal cancer situ multicentric invasive ductal cancer No nipple/areola central breast cancer ( least 2 cm areola ) No metastatic disease Hormone receptor status : Not specify PATIENT CHARACTERISTICS : Age Over 18 Sex Not specify Menopausal status Not specify Performance status Not specify Life expectancy Not specify Hematopoietic Not specify Hepatic Not specify Renal Not specify Other Not pregnant Negative pregnancy test No known allergy intolerance patent blue V dye PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy Not specify Endocrine therapy Not specify Radiotherapy Not specify Surgery No prior surgery cancer Other No prior neoadjuvant treatment cancer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>stage I breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
</DOC>